手机版 客户端

靶向结肠炎症部位巨噬细胞的口服给药系统的构建及评价

靶向结肠炎症部位巨噬细胞的口服给药系统的构建及评价
  • 导航:首页 > 科学基金
  • 批准号:81773663
  • 批准年度: 2017年
  • 学科分类:药剂学(H3008) |
  • 项目负责人:邢建峰
  • 负责人职称:教授
  • 依托单位:西安交通大学
  • 资助金额:59.5万元
  • 项目类别:面上项目
  • 研究期限:2018年01月01日 至 2021年12月31日
  • 中文关键词: 结肠;炎症;部位;巨噬细胞;口服
  • 英文关键词:Ulcerative colitis;Macrophage;Nuclear factor-kappa B;Oral colon-specific drug delivery system;Budeso

项目摘要

中文摘要

肠道巨噬细胞NF-κB信号通路的活化,在溃疡性结肠炎(UC)发病中起关键作用,抑制其活化成为治疗UC的有效靶点。本项目通过构建靶向结肠炎症部位巨噬细胞的口服给药系统递送siRNA和药物,抑制NF-κB信号通路活化,阻断炎症级联反应。首先制备甘露糖修饰共载siRNA和布地奈德的纳米粒(NP),并包载于氧化敏感的炎症靶向水凝胶纤维(GEL-NP)中,再以HPMCAS包衣制备pH敏感微球。在结肠环境中,该pH敏感微球溶解释放GEL-NP,其借静电作用黏附于炎症部位,在炎症过氧化环境中其所含二硒键断裂并释放NP;NP通过表面甘露糖主动靶向巨噬细胞,并借助聚乙烯亚胺的溶酶体逃逸作用,完成NF-κBp65 siRNA和布地奈德的传递,实现RNA干扰与药物发挥协同作用。在考察给药系统制备工艺和各级生物响应性的基础上,通过动物实验评价其有效性。本项目可为靶向炎症部位巨噬细胞治疗UC提供新的研究思路和方法。

英文摘要

The activation of NF-κB signaling pathway in colonic macrophages plays a key role in the pathogenesis of ulcerative colitis, therefore, the inhibition of NF-κB could become an effective target for ulcerative colitis treatment. In this study, we aimed to develop an oral colon-specific drug delivery system for targeting and co-delivering drugs and siRNA to macrophages at the inflammatory site, in order to inhibit the activation of NF-κB signaling pathway and block the inflammatory cascade. Briefly, a mannose-modified nanoparticle (NP) that co-delivery NF-κBp65 siRNA and budesonide is developed and loaded in a redox-sensitive hydrogel microfiber (GEL-NP), which is further coated with hydroxypropyl methylcellulose acetate succinate to form a pH-sensitive microsphere (MP-GEL-NP). In the colon environment, the MP-GEL-NP is degraded at alkaline pH and releases the GEL-NP, which could adhere to the inflammatory site by electrostatic adsorption, meanwhile, the diselenide bonds contained in the GEL-NP would be specifically cleaved in the inflammatory environment for further releasing the NP. Subsequently, the NP could actively target the macrophages via mannose receptor-mediated endocytosis. Finally, the polyethyleneimine unit contained in the NP would achieve the intracellular release of NF-κBp65 siRNA and budesonide through the ability of endosomal escape. Consequently, the RNA interference and the glucocorticoid might provide a synergistic effect on the treatment of ulcerative colitis. Finally, based on the investigation of the preparation process and the multi bio-responsiveness of the system, the therapeutic effect of MP-GEL-NP is evaluated by animal experiments. This study could also provide new research idea and methods for the treatment of ulcerative colitis through targeting the macrophages at the inflammatory site.

评估说明

    国家自然科学基金项目“靶向结肠炎症部位巨噬细胞的口服给药系统的构建及评价”发布于爱科学iikx,并永久归类于相关科学基金导航中,仅供广大科研工作者查询、学习、选题参考。国科金是根据国家发展科学技术的方针、政策和规划,以及科学技术发展方向,面向全国资助基础研究和应用研究,发挥着促进我国基础研究源头创新的作用。国科金的真正价值在于它能否为科学进步和社会发展带来积极的影响。

此文由 爱科学 编辑!:首页 > 科学基金 > 科学基金4 » 靶向结肠炎症部位巨噬细胞的口服给药系统的构建及评价

推荐文章